Article
Kv1.3 inhibition alleviates neuropathology via neuroinflammatory and resilience pathways in a mouse model of Aβ pathology
2025-12-25
Abstract excerpt
<h4>ABSTRACT</h4> Inhibition of voltage-gated potassium channel Kv1.3 is a therapeutic strategy to curb microglia-mediated neuroinflammation in neurodegeneration, although the cellular and signaling mechanisms of disease-modification by Kv1.3 blockers are unclear. In this study, we delineate protective mechanisms of Kv1.3 blockade in a mouse model of Alzheimer’s disease (AD) pathology using comprehensive transcri...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0b3b4031-0848-5b94-b077-a761e418bacd
- DOI
- 10.64898/2025.12.25.696456
